Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study
2008

Prognostic Value of uPAR in Oral Cancer

Sample size: 189 publication Evidence: moderate

Author Information

Author(s): Bacchiocchi Roberta, Rubini Corrado, Pierpaoli Elisa, Borghetti Giulia, Procacci Pasquale, Nocini Pier Francesco, Santarelli Andrea, Rocchetti Romina, Ciavarella Domenico, Lo Muzio Lorenzo, Fazioli Francesca

Primary Institution: Polytechnic University of the Marche Region

Hypothesis

Can uPAR expression serve as a prognostic marker in oral squamous cell carcinoma (OSCC)?

Conclusion

uPAR may be a useful biomarker to identify higher risk subgroups of OSCC patients.

Supporting Evidence

  • 39.1% of OSCC cases showed uPAR positivity.
  • uPAR expression correlated with tumor differentiation grade.
  • Patients with uPAR positive tumors had a lower life expectancy.

Takeaway

This study found that a protein called uPAR can help doctors understand which patients with oral cancer might be at higher risk for serious problems.

Methodology

The study analyzed uPAR expression in tissue samples from 189 OSCC patients using immunohistochemistry.

Potential Biases

Potential biases in histopathological evaluation and patient selection.

Limitations

The study is retrospective and may have biases related to sample selection.

Participant Demographics

143 males and 46 females, aged 33 to 95 years.

Statistical Information

P-Value

0.0053

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-8-220

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication